| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $7.48B | +51.6% |
| Cost of Revenue | $4.29B | +56.1% |
| Gross Profit | $3.18B | +46.0% |
| R&D Expense | $32.9M | +6.8% |
| SG&A Expense | $1.74B | +59.3% |
| Operating Income | $754.9M | +19.0% |
| Pre-tax Income | $481.0M | -4.6% |
| Income Tax | $95.7M | -19.3% |
| Net Income | $384.1M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Accounts Receivable | $358.5M | -11.4% |
| Inventory | $630.0M | +40.9% |
| Current Assets | $1.29B | +21.5% |
| Total Assets | $11.60B | +94.0% |
| Current Liabilities | $1.57B | +63.0% |
| Long-term Debt | $4.61B | +22.7% |
| Total Liabilities | $8.48B | +56.8% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $800.1M | +20.0% |
| Capital Expenditures | $166.9M | +71.5% |
| Investing Cash Flow | -$3.02B | -3027.5% |
| Financing Cash Flow | $616.9M | -42.7% |
| Free Cash Flow | $633.2M | +11.2% |
| -0.1% |
| EPS (Basic) | $1.86 | -15.8% |
| EPS (Diluted) | $1.84 | -14.8% |
| Stockholders' Equity |
| $3.11B |
| +456.0% |